Atai life sciences announces key clinical pipeline and corporate updates

New york and berlin, march 06, 2023 (globe newswire) -- atai life sciences (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, provided key clinical pipeline and corporate updates.
ATAI Ratings Summary
ATAI Quant Ranking